There are currently two approved drugs to treat ALS: riluzole, which can extend lifespan by an average of a few months and has been on the market for 25 years, and the 2017-approved edaravone, which was shown in clinical trials to help patients function for longer into their disease

Categories: Stem Cells therapy

NBScience

contract research organization

stem cell therapy